Healthcare Solutions Mgmt. Group Inc. (HSMD)

[VETERANTRADER]

RE: And before you feed it to humans, you begin and complete those clinical trials.



The company previously announced AquaLiv representatives would be visiting Kenya to make preparations for an upcoming clinical trial of NatuRx(TM) HIV/AIDS. According to the company, while attempting to register the treatment as a drug, Kenyan officials instead recommended filing as an alternative medicine.

"Unlike traditional drugs, all NatuRx(TM) treatments are information-based and do not rely on chemical interaction with active molecules to function," stated AquaLiv CEO, Craig Hoffman. "The Kenyan authorities recognized that our unique treatment has a negligible toxicity and cannot be misused. It is impossible to overdose. In our first regulatory organization experience with NatuRx(TM), the treatment was acknowledged and understood far easier than we anticipated."